Literature DB >> 26912743

Simultaneous Platelet P2Y12 and P2Y1 ADP Receptor Blockade: Are Two Better Than One?

Muthiah Vaduganathan1, Deepak L Bhatt2.   

Abstract

Entities:  

Keywords:  Editorial; acute coronary syndrome; blood platelets; pharmacology; platelet aggregation inhibitors; thrombosis

Mesh：

Substances：

Year:  2016        PMID： 26912743     DOI： 10.1161/ATVBAHA.115.307097

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  3 in total

Review 1.  Platelet Signaling Pathways and New Inhibitors.

Authors:  Steven P Grover; Wolfgang Bergmeier; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04       Impact factor: 8.311

Review 2.  Novel Antiplatelet Therapies for Atherothrombotic Diseases.

Authors:  Arjun Majithia; Deepak L Bhatt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

3.  Prevention of P2 Receptor-Dependent Thrombocyte Activation by Pore-Forming Bacterial Toxins Improves Outcome in A Murine Model of Urosepsis.

Authors:  Mette G Christensen; Nanna Johnsen; Marianne Skals; Aimi D M Hamilton; Peter Rubak; Anne-Mette Hvas; Helle Praetorius
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.